Clinical Trial Update: CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating CD7-directed CAR-T therapy for relapsed/refractory CD7-positive T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• CD7 CAR-T (CD7-directed chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: He Huang | Conditions: Neoplasms, Hematologic Neoplasms | EARLY_Phase 1 | Status: COMPLETED